MedTrace Logo

Spurring Innovation to Promote HIV Testing: An RCT Evaluating Crowdsourcing

NCT02248558 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 721

Last updated 2017-02-10

Study results available
· View outcomes & findings →

Summary

Crowdsourcing may be a powerful tool to spur the development of innovative videos to promote HIV testing among key populations such as men who have sex with men (MSM) and transgender (TG) individuals. The purpose of this randomized controlled trial is to compare the effect of a crowdsourced video and a conventional video on first-time HIV testing among MSM and TG in China. The crowdsourced video was developed using an open contest, formal transparent judging, and an incentive of marketing promotion. The hypothesis is that a crowdsourced video will be equivalent (within a margin of 3%) to a conventional video in terms of self-reported first-time HIV testing within 3-4 weeks of watching the video.

Conditions

Interventions

BEHAVIORAL

Conventional Video

Participants will watch a one minute video whose purpose is to increase HIV testing uptake. This video was created by a local CDC via direct CDC funding and internal guidance and development.

BEHAVIORAL

Crowdsourced Video

Participants will watch a one minute video whose purpose is to increase HIV testing uptake. This video was the winner in a crowdsourced video contest hosted in China. CBOs all submitted their own independently designed and funded videos.

Sponsors & Collaborators

  • Social Entrepreneurship to Spur Health

    collaborator OTHER

  • University of California, San Francisco

    collaborator OTHER

  • London School of Hygiene and Tropical Medicine

    collaborator OTHER

  • Guangdong Provincial Centers for Skin Diseases and STI Control

    collaborator UNKNOWN

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Joseph Tucker · UNC Project-China

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02248558 on ClinicalTrials.gov